Home › Massachusetts is investigating high cost of hepatitis C drug
 

Keywords :   


Massachusetts is investigating high cost of hepatitis C drug

2016-01-27 20:23:56| Biotech - Topix.net

The Massachusetts attorney general's office is investigating whether the makers of a breakthrough treatment for hepatitis C are violating state law by pricing the drug too high. Attorney General Maura Healey on Wednesday released a letter sent to the chief executive of California-based Gilead Sciences Inc. In it, Healey said her office was examining whether the pricing constituted an unfair trade practice.

Tags: high cost drug massachusetts

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
21.051-800-Flowers To Sell Air Wick-Inspired Flower Bouquets
21.05Water firms ask for bill rises of between 24% and 91%
21.052024 National feeder and stocker receipts down 6 percent from 2023
21.05XSYS launches nyloflex eco flexo plate series
21.05Self-fed lick tubs for supplementing protein to grazing cattle
21.05Global Luxury Perfume Market Size Projected To Grow By $5.59 Billion from 2024-2028: Technavio
21.05Paul Mitchell Unveils New Pet Grooming Line
21.05USDA awards $300 million to diversify export markets for U.S. agriculture
More »